| Ms Danielle M Pelletier, CNM | |
|
118 Northport Ave, Belfast, ME 04915-6009 | |
| (207) 338-9345 | |
| Not Available |
| Full Name | Ms Danielle M Pelletier |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 118 Northport Ave, Belfast, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770920100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNM172001 (Maine) | Primary |
| Entity Name | Waldo County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841397932 PECOS PAC ID: 2163332883 Enrollment ID: O20040428001058 |
News Archive
The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of Cancer Cell. The study adds to growing evidence that combination therapies targeting different phases of the cell division cycle are vital for optimal cancer treatment.
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of Cancer Cell. The study adds to growing evidence that combination therapies targeting different phases of the cell division cycle are vital for optimal cancer treatment.
› Verified 5 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of Cancer Cell. The study adds to growing evidence that combination therapies targeting different phases of the cell division cycle are vital for optimal cancer treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Danielle M Pelletier, CNM 118 Northport Ave, Belfast, ME 04915-6009 Ph: (207) 338-9345 | Ms Danielle M Pelletier, CNM 118 Northport Ave, Belfast, ME 04915-6009 Ph: (207) 338-9345 |
News Archive
The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of Cancer Cell. The study adds to growing evidence that combination therapies targeting different phases of the cell division cycle are vital for optimal cancer treatment.
› Verified 5 days ago
Rachel Zaccaria, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 16 Fahy St Ste 108, Belfast, ME 04915 Phone: 207-505-4332 Fax: 207-536-3201 |